Skip to main content
Terug
Watch Compare

MapLight Therapeutics, Inc.

Datakwaliteit: 83%
MPLT
NASDAQ Manufacturing Chemicals
€ 26,73
▼ € 2,68 (-9,11%)
Marktkapitalisatie: 1,31 B
Prijs
€ 28,77
Marktkapitalisatie
1,31 B
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -138,61 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-35,16%
Boven sectorgemiddelde (-53,58%)
ROIC-28,83%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio13,22
Interest CoverageN/A

Waardering

PE (TTM)
-8,10
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -8,1 -1,5
P/B — 1,6
ROE % -35,2 -53,6
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

6 analisten
Buy
Huidig
€ 26,73
+22.2%
Koersdoel
€ 32,67
€ 28,00
€ 33,00
€ 37,00
Vooruitzicht
Forward K/W -7,15
Forward WPA -€ 3,74
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 3,74
-€ 4,17 – -€ 3,25
 0,0 3
FY2026 -€ 4,61
-€ 5,75 – -€ 3,45
 0,0 3

Winstverassingen

Laatste 2 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,83 -€ 2,47 -197,6%
Q32025 -€ 1,73 -€ 37,18 -2055,4%

ETFs Holding This Stock

IRSIX IRSIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight
VVICX VVICX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -161,15 M
ROE -35,16% ROA -33,61%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138,61 M
ROIC -28,83% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13,22
Interest Coverage N/A Asset Turnover N/A
Working Capital 226,74 M Tangible Book Value -274,18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,10 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,62%
Market Cap 1,31 B Enterprise Value 1,24 B
Per Share
EPS (Diluted TTM) -18,56 Revenue / Share N/A
FCF / Share -3,05 OCF / Share -3,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86,01%
SBC-Adj. FCF -174,62 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -161,15 M
EPS (Diluted) -18,56
Gross Profit —
Operating Income -169,08 M
EBITDA —
R&D Expenses 138,35 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 479,51 M
Total Liabilities 21,14 M
Shareholders' Equity 458,37 M
Total Debt —
Cash & Equivalents 46,73 M
Current Assets 324,67 M
Current Liabilities 16,23 M